Obese Patients With Type 2 Diabetes

• Status: Completed
• Trial end date: 2004-05-01
• Target enrollment: 0
• Participant gender: All

Summary

To assess the effect on weight loss and weight maintenance over a period of one year when prescribed with a hypocaloric diet in obese patients with Type 2 Diabetes

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Sanofi
• Treatments: Rimonabant

Criteria

• BMI must be greater than 27 and less than 40

• Treated Type 2 Diabetes on single therapy treatment for at least 1 year

• Stable weight (variation of less than 5 kg within 3 months prior to screening visit)